E&C Unveils Revised Right To Try Bill For Tuesday Floor Vote, But Bill Doesn’t Win Over Patient Advocates

March 12, 2018 at 4:11 PM
House Energy & Commerce Committee Republicans’ attempts to craft a Right to Try bill that patient advocates can support appears to have failed, with major groups refusing to back anything that cuts FDA out of the process. However the new bill does appear to answer many of the concerns laid out by FDA Commissioner Scott Gottlieb by narrowing the patient population covered and revising the informed consent process. E&C Chairman Greg Walden (R-OR) and Rep. Michael Burgess (R-TX) unveiled a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.